首页> 外国专利> Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections

Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections

机译:用于预防和/或治疗呼吸道感染的单价,二价和三价抗人类呼吸合胞病毒(HRSV)纳米体构建体

摘要

Amino acid sequences are provided that are directed against/and or that can specifically bind protein F of hRSV, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. The amino acid sequences, polypeptides and therapeutic compounds and compositions provided by the invention show an improved stability, less immunogenicity and/or improved affinity and/or avidity for protein F of hRSV.;The invention also relates to the uses of such amino acid sequences, polypeptides, compounds or constructs for prophylactic and/or therapeutic purposes.
机译:提供了氨基酸序列,其涉及/和或可以特异性地结合HRSV的蛋白F,以及化合物或构建体,以及尤其是蛋白质和多肽,其包含或基本上由一种或多种这样的氨基酸序列组成。本发明提供的氨基酸序列,多肽和治疗化合物及组合物显示出HRSV蛋白F的改善的稳定性,较少的免疫原性和/或改善的亲和力和/或亲和力。;本发明还涉及这种氨基酸序列的用途,用于预防和/或治疗目的的多肽,化合物或构建体。

著录项

  • 公开/公告号US11028151B2

    专利类型

  • 公开/公告日2021-06-08

    原文格式PDF

  • 申请/专利权人 ABLYNX N.V.;

    申请/专利号US201715712247

  • 申请日2017-09-22

  • 分类号C07K16/10;A61M11;A61M15;A61K39;

  • 国家 US

  • 入库时间 2022-08-24 19:05:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号